Life Science Leader — April 2013 Outsourcing and the oral solid dose: Will challenges lead to new patterns of outsourcing? Life Science Leader — CRO Leadership Awards supplement issue Strategic Outsourcing Often Means Combining Functional and Full-Service CROs 
 
May 10 Life Science Leader's May issue includes results from Nice Insight annual research April 10 Learn about Trends in Outsourcing the Oral Solid Dose in April's Outsourcing Insights 
"Nice Insight’s thought-provoking data gave me new insight into existing
companies that outsource research and manufacturing services and products."
Director of Chemical Product R&D, Specialty Pharmaceutical Company, North America  
Pharma Chem Outsourcing 2013
September 16-18 Long Branch, NJ |
Abiogen Pharma s.p.a. Aenova Avema Pharma Solutions Corealis Pharma, Inc. Hanford Pharmaceuticals Murty Pharmaceuticals, Inc. Takeda Pharmaceuticals International GmbH Pharmatek Laboratories, Inc. UPM Pharmaceuticals, Inc. Xcelience LLC Pillar5 Pharma, Inc
Pillar5 Pharma, Inc. operates as a contract manufacturing organization for the pharmaceutical industry. The company emphasizes its capabilities in the area of manufacturing and packaging oral solid and sterile ophthalmic products. Services include blending, fluid bed drying, high and low shear granulation, roller compaction, compression, encapsulation, and tablet coating. It also offers its microbiological testing services for pharmaceutical, biological, nutraceutical, natural health, and consumer products. The company acquired its cGMP compliant manufacturing facility, which was established in 1956 by Pfizer Canada Inc. http://www.pillar5pharma.com
Regions
Americas Stock Symbol Private Filter of Pillar5 Pharma, Inc's services per Nice Insight Categories
Contact Pillar5 Pharma, Inc 
|
|
|
